tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market

GlaxoSmithKline (GSK) Technical Analysis

Compare
4,943 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is -0.96, suggesting GlaxoSmithKline is a Buy.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 36.64, while GlaxoSmithKline’s (GSK) share price is $35.28, making it a Sell.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 36.91, while GlaxoSmithKline’s (GSK) share price is $35.28, making it a Sell.

GlaxoSmithKline (GSK) Pivot Points

Apr 16, 2025, 05:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
32.60
33.06
33.85
34.32
35.11
35.57
36.36
Fibonacci
33.06
33.54
33.84
34.32
34.80
35.09
35.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Apr 16, 2025, 05:27 AM
Period
Simple
Exponential
MA5
34.43Buy
34.94Buy
MA10
35.80Sell
35.66Sell
MA20
37.40Sell
36.64Sell
MA50
37.42Sell
36.91Sell
MA100
35.55Sell
36.71Sell
MA200
37.17Sell
37.83Sell
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 35.66, while GlaxoSmithKline’s (GSK) share price is $35.28, making it a Sell.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 36.71, while GlaxoSmithKline’s (GSK) share price is $35.28, making it a Sell.
GlaxoSmithKline’s (GSK) stock price is $35.28 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 37.42, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $35.28 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 35.55, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $35.28 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 37.17, creating a Sell signal.

GlaxoSmithKline (GSK) Technical Indicators

Apr 16, 2025, 05:27 AM
Name
Value
Implied Action
RSI (14)
41.03
Neutral
STOCH (9,6)
31.30
Neutral
STOCHRSI (14)
30.96
Neutral
MACD (12,26)
-0.96
Buy
ADX (14)
26.43
Neutral
Williams %R
-57.32
Buy
CCI (14)
-79.83
Neutral
ATR (14)
1.19
-
Ultimate Oscillator
49.22
Neutral
ROC
-8.55
Sell
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 41.03, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 26.43, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is -79.83, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is -8.55, creating a Sell signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Sell.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 41.03, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is -0.96, which suggests GSK is a Buy.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 34.43, which suggests GSK is a Buy.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 37.40, which suggests GSK is a Sell.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 37.42, which suggests GSK is a Sell.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 37.17, which suggests GSK is a Sell.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -57.32, which suggests GSK is a Buy.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is -79.83, which suggests GSK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis